This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Medical Informatics, is properly cited. The complete bibliographic information, a link to the original publication on https://medinform.jmir.org/, as well as this copyright and license information must be included.
https://medinform.jmir.org/2022/8/e37842
In “Identifying Patients Who Meet Criteria for Genetic Testing of Hereditary Cancers Based on Structured and Unstructured Family Health History Data in the Electronic Health Record: Natural Language Processing Approach” (JMIR Med Inform 2022;10(8):e37842), the authors noted the following corrections:
(1) In the originally published paper, the following sentence was present in the Methods section of the Abstract:
Algorithms were developed based on the National Comprehensive Cancer Network (NCCN) guidelines for genetic testing for hereditary breast or ovarian and colorectal cancers.
This has been changed to:
Algorithms were developed based on the National Comprehensive Cancer Network (NCCN) guidelines for genetic testing for hereditary breast, ovarian, pancreatic, and colorectal cancers.
(2) Textbox 1 has been revised for clarity and accuracy, and to comply with the citation guidelines of the National Comprehensive Cancer Network (NCCN).
(3) In the originally published paper, the following sentence was present in the Background section:
The National Comprehensive Cancer Network (NCCN) has published a set of evidence-based guidelines for genetic testing of hereditary cancers, including breast, ovarian, and colorectal cancers.
This has been changed to:
The National Comprehensive Cancer Network (NCCN) has published a set of evidence-based guidelines for genetic testing of hereditary cancers, including breast, ovarian, pancreatic, and colorectal cancers.
(4) References [6] and [7] have been updated to the following with NCCN's permission and disclaimer statements:
6. Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, et al. NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020. J Natl Compr Canc Netw 2020 Apr;18(4):380-391 [Referenced with permission from the National Comprehensive Cancer Network, Inc. 2020]. [doi: 10.6004/jnccn.2020.0017] [Medline: 32259785]
7. Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, et al. NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 2.2019. J Natl Compr Canc Netw 2019 Sep 01;17(9):1032-1041 [Referenced with permission from the National Comprehensive Cancer Network, Inc. 2020]. [doi: 10.6004/jnccn.2019.0044] [Medline: 31487681]
Excerpt of National Comprehensive Cancer Network (NCCN) criteria for unaffected individuals’ family history–based genetic testing of breast, ovarian, pancreatic, and colorectal cancers (referenced with permission).
Breast or ovarian cancer:
First- or second-degree relative with breast cancer at age ≤45 years
First- or second-degree relative with ovarian cancer
First-degree relative with pancreatic cancer
Breast cancer in a male relative
Three or more first- or second-degree relatives with breast or prostate cancer on the same side of the family
Ashkenazi Jewish and any breast or prostate cancer in any relative at any age
BRCA1/2, CHEK2, ATM, PALB2, TP53, PTEN, or CDH1 genes, Cowden Syndrome, Li-Fraumeni Syndrome in any relative at any age
Colorectal cancer:
MLH1, MSH2, PMS2, MSH6, EPCAM, MYH, or MUTYH genes, Lynch syndrome, familial adenomatous polyposis (FAP), adenomatous polyposis coli (APC), serrated polyposis or polyposis discovered in the coded family history
First-degree relative with colon cancer at ≤50 years
First-degree relative with endometrial cancer at ≤50 years
Three or more first- or second-degree relatives with Lynch syndrome, HNPCC, colon cancer, endometrial, uterine, ovarian, stomach, gastric, small bowel, small intestine, kidney, ureteral, bladder, urethra, brain, pancreas, also all on the same side of the family
The correction will appear in the online version of the paper on the JMIR Publications website on September 13, 2022, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.
DalyMBPilarskiRYurgelunMBBerryMPBuysSSDicksonPDomchekSMElkhananyAFriedmanSGarberJEGogginsMHuttonMLKhanSKleinCKohlmannWKurianAWLarongaCLittonJKMakJSMenendezCSMerajverSDNorquistBSOffitKPalTPedersonHJReiserGShannonKMVisvanathanKWeitzelJNWickMJWisinskiKBDwyerMADarlowSDNCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020J Natl Compr Canc Netw20200418438091[Referenced with permission from the National Comprehensive Cancer Network, Inc. 2020]10.6004/jnccn.2020.001732259785jnccnGLINS1804GuptaSProvenzaleDLlorXHalversonALGradyWChungDCHaraldsdottirSMarkowitzAJSlavinTPHampelHNessRMWeissJMAhnenDJChenLCooperGEarlyDSGiardielloFMHallMJHamiltonSRKanthPKlapmanJBLazenbyAJLynchPMMayerRJMikkelsonJPeterSRegenbogenSEDwyerMAOgbaNNCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 2.2019J Natl Compr Canc Netw20190901179103241[Referenced with permission from the National Comprehensive Cancer Network, Inc. 2020]10.6004/jnccn.2019.004431487681jnccnGLsINScolongenetics1709